Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310037161> ?p ?o ?g. }
- W4310037161 abstract "Background Management of advanced chordomas remains delicate considering their insensitivity to chemotherapy. Homozygous deletion of the regulatory gene CDKN2A has been described as the most frequent genetic alteration in chordomas and may be considered as a potential theranostic marker. Here, we evaluated the tumor efficacy of the CDK4/6 inhibitor palbociclib, as well as the PLK1 inhibitor volasertib, in three chordoma patient-derived xenograft (PDX) models to validate and identify novel therapeutic approaches. Methods From our chordoma xenograft panel, we selected three models, two of them harboring a homozygous deletion of CDKN2A/2B genes, and the last one a PBRM1 pathogenic variant (as control). For each model, we tested the palbociclib and volasertib drugs with pharmacodynamic studies together with RT-PCR and RNAseq analyses. Results For palbociclib, we observed a significant tumor response for one of two models harboring the deletion of CDKN2A/2B (p = 0.02), and no significant tumor response in the PBRM1 -mutated PDX; for volasertib, we did not observe any response in the three tested models. RT-PCR and RNAseq analyses showed a correlation between cell cycle markers and responses to palbociclib; finally, RNAseq analyses showed a natural enrichment of the oxidative phosphorylation genes (OxPhos) in the palbociclib-resistant PDX (p = 0.02). Conclusion CDK4/6 inhibition appears as a promising strategy to manage advanced chordomas harboring a loss of CDKN2A/2B . However, further preclinical studies are strongly requested to confirm it and to understand acquired or de novo resistance to palbociclib, in the peculiar view of a targeting of the oxidative phosphorylation genes." @default.
- W4310037161 created "2022-11-30" @default.
- W4310037161 creator A5002183430 @default.
- W4310037161 creator A5006332501 @default.
- W4310037161 creator A5031492896 @default.
- W4310037161 creator A5037964830 @default.
- W4310037161 creator A5042305744 @default.
- W4310037161 creator A5051262831 @default.
- W4310037161 creator A5058494604 @default.
- W4310037161 creator A5059398124 @default.
- W4310037161 creator A5070173384 @default.
- W4310037161 creator A5075567455 @default.
- W4310037161 creator A5079715350 @default.
- W4310037161 creator A5089229030 @default.
- W4310037161 creator A5090178944 @default.
- W4310037161 creator A5090449847 @default.
- W4310037161 date "2022-11-25" @default.
- W4310037161 modified "2023-10-17" @default.
- W4310037161 title "In vivo efficacy assessment of the CDK4/6 inhibitor palbociclib and the PLK1 inhibitor volasertib in human chordoma xenografts" @default.
- W4310037161 cites W1175827129 @default.
- W4310037161 cites W1483871710 @default.
- W4310037161 cites W1503533733 @default.
- W4310037161 cites W1564861257 @default.
- W4310037161 cites W1969630915 @default.
- W4310037161 cites W1979378169 @default.
- W4310037161 cites W1988995169 @default.
- W4310037161 cites W1992252639 @default.
- W4310037161 cites W1997073961 @default.
- W4310037161 cites W2005657436 @default.
- W4310037161 cites W2007419457 @default.
- W4310037161 cites W2007852760 @default.
- W4310037161 cites W2019517928 @default.
- W4310037161 cites W2022538460 @default.
- W4310037161 cites W2029108033 @default.
- W4310037161 cites W2056035945 @default.
- W4310037161 cites W2078165554 @default.
- W4310037161 cites W2082064668 @default.
- W4310037161 cites W2083486480 @default.
- W4310037161 cites W2093421736 @default.
- W4310037161 cites W2112866395 @default.
- W4310037161 cites W2117692326 @default.
- W4310037161 cites W2127675410 @default.
- W4310037161 cites W2135813885 @default.
- W4310037161 cites W2136685069 @default.
- W4310037161 cites W2143319350 @default.
- W4310037161 cites W2152248266 @default.
- W4310037161 cites W2155899435 @default.
- W4310037161 cites W2168654351 @default.
- W4310037161 cites W2170583701 @default.
- W4310037161 cites W2337998143 @default.
- W4310037161 cites W2467902526 @default.
- W4310037161 cites W2564066883 @default.
- W4310037161 cites W2586748258 @default.
- W4310037161 cites W2611022823 @default.
- W4310037161 cites W2745714473 @default.
- W4310037161 cites W2760852017 @default.
- W4310037161 cites W2766060270 @default.
- W4310037161 cites W2807750039 @default.
- W4310037161 cites W2889701300 @default.
- W4310037161 cites W2894062761 @default.
- W4310037161 cites W2899130161 @default.
- W4310037161 cites W2902401096 @default.
- W4310037161 cites W2909620693 @default.
- W4310037161 cites W2968141411 @default.
- W4310037161 cites W2968474136 @default.
- W4310037161 cites W2970421232 @default.
- W4310037161 cites W2996622750 @default.
- W4310037161 cites W2999755501 @default.
- W4310037161 cites W3011770496 @default.
- W4310037161 cites W3024684302 @default.
- W4310037161 cites W3026436836 @default.
- W4310037161 cites W3027057217 @default.
- W4310037161 cites W3027940102 @default.
- W4310037161 cites W3037252669 @default.
- W4310037161 cites W3037624356 @default.
- W4310037161 cites W3045753156 @default.
- W4310037161 cites W3046562558 @default.
- W4310037161 cites W3048840742 @default.
- W4310037161 cites W3081729395 @default.
- W4310037161 cites W3098241202 @default.
- W4310037161 cites W3107964109 @default.
- W4310037161 cites W3111645267 @default.
- W4310037161 cites W3120241209 @default.
- W4310037161 cites W3127588932 @default.
- W4310037161 cites W3134900802 @default.
- W4310037161 cites W3153785355 @default.
- W4310037161 cites W3168004909 @default.
- W4310037161 cites W3200632075 @default.
- W4310037161 cites W3202924187 @default.
- W4310037161 cites W4220772782 @default.
- W4310037161 cites W4243903519 @default.
- W4310037161 cites W4298000641 @default.
- W4310037161 doi "https://doi.org/10.3389/fonc.2022.960720" @default.
- W4310037161 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36505864" @default.
- W4310037161 hasPublicationYear "2022" @default.
- W4310037161 type Work @default.
- W4310037161 citedByCount "3" @default.
- W4310037161 countsByYear W43100371612023 @default.
- W4310037161 crossrefType "journal-article" @default.
- W4310037161 hasAuthorship W4310037161A5002183430 @default.